Oncology Biosimilar Market by Cancer Type (Breast Cancer, Colorectal Cancer, Blood Cancer, Neutropenia Cancer, Non-Small Cell Lung Cancer, and Others), By Drug Type (mAb, Immunomodulators, Hematopoietic Agents, G-CSF, and Others), By Distribution Channel (Retail Pharmacies, Hospital Pharmacy, and Online Pharmacy): Global Industry Perspective, Comprehensive Analysis and Forecast, 2017 - 2024

Global oncology biosimilar market expected to generate revenue of around USD 13,993.64 million by end of 2024, growing at a CAGR of around 26.8% between 2018 and 2024. Biosimilar is the identical copy of oncology biologics used for the treatment of cancer and officially approved for the treatment of cancer.

12-Jul-2018 | Number of pages: 110 | Report Code: ZMR-3228 | Report Format : | Status : Published

Abstract

The report covers forecast and analysis for the oncology biosimilar market on a global and regional level. The study provides historical data from 2015 to 2017 along with a forecast from 2018 to 2024 based revenue (USD Million). The study includes drivers and restraints for the oncology biosimilar market along with the impact they have on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the oncology biosimilar market on a global level.

In order to give the users of this report a comprehensive view on the oncology biosimilar market, we have included competitive landscape and analysis of Porter’s Five Forces model for the market. The study encompasses a market attractiveness analysis, where test type, drug type, distribution channel and regional segmentation are benchmarked based on their market size, growth rate, and general attractiveness.

Global Oncology Biosimilar Market

The report provides company market share analysis in order to give a broader overview of the key players in the market. In addition, the report also covers key strategic developments of the market, including acquisitions & mergers, new test type launch, agreements, partnerships, collaborations & joint ventures, research & development, regional expansion of major participants involved on the market on the global and regional basis.

The study provides a decisive view on the oncology biosimilar market by segmenting the market based on test type, drug type, distribution channel, and regions. All the segments have been analyzed based on present and future trends and the market are estimated from 2018 to 2024. 

Based on test type, the oncology biosimilar market is segmented as breast cancer, colorectal cancer, blood cancer, neutropenia cancer, non-small cell lung cancer and others. Based on the distribution channel, the oncology biosimilar market is segmented as retail pharmacies, hospital pharmacy, and online pharmacy. 

Increasing demand for affordable therapies due to the constant increase in cancer patients is one of the major driving factors of oncology biosimilar market. High medical expenses associated with cancer treatment; the lack of awareness and dearth of skilled personnel are factors that influence the market growth during the forecast period.

The regional segmentation includes the current and forecast demand for North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa with its further bifurcation into major countries, including the U.S., Canada, Mexico, Germany, Spain, Italy, France, UK, China, Japan, India, and Brazil. This segment includes demand for oncology biosimilar market based on individual segment and test types in all the regions and countries.

The report also includes detailed profiles of end players such as Teva Pharmaceutical Industries Ltd., Biocon, STADA Arzneimittel AG, Sandoz International GmbH, Intas Pharmaceuticals Ltd., Celltrion Inc., Pfizer Inc., Apotex Inc., Dr. Reddy’s Laboratories Ltd., and BIOCAD, among others. 

This report segments the global oncology biosimilar market as follows:

Global Oncology Biosimilar Market: by Test Type

  • Breast Cancer
  • Colorectal Cancer
  • Blood Cancer
  • Neutropenia Cancer
  • Non-Small Cell Lung Cancer
  • Others

Global Oncology Biosimilar Market: Drug Type Segment Analysis:

  • mAb
  • Immunomodulators
  • Hematopoietic Agents
  • G-CSF 
  • Others

Global Oncology Biosimilar Market: by Distribution Channel

  • Retail Pharmacies
  • Hospital Pharmacy
  • Online Pharmacy

Global Oncology Biosimilar Market: by Region

  • North America
    • The U.S.
  • Europe
    • UK
    • France
    • Germany
  • Asia Pacific
    • China
    • Japan
    • India
  • Latin America
    • Brazil
  • Middle East and Africa

Related Reports

Diagnostic Specialty Enzyme Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts 2018–2026

Price : $ 3999.00 | Report Code: ZMR-3628 | Report Format:

Global Diagnostic Specialty Enzymes Market: Overview Diagnostic specialty enzymes find applications in low volume and high value-added applications. Major use of diagnostic specialty enzymes is in clinical chemistry, molecular diagnostics, and immunoassay. They help in reduction of systemic infl...Read More

Calcitriol Market by Product Type (Calcitriol Capsule, Calcitriol Solution, and Others), by Application (Osteoporosis, Renal Osteodystrophy, and Others), and by Distribution Channel (Direct Sales and Distributor): Global Industry Perspective, Comprehensive Analysis, and Forecast, 2017 – 2024

Dec-2018 | Price : $ 4899.00 | Pages: 110 | Report Code: ZMR-3601 | Report Format:

The report covers a forecast and an analysis for the Calcitriol Market on a global and regional level. The study provides historical data from 2015 to 2017 along with a forecast from 2018 to 2024 based revenue (USD Million). The study includes drivers and restraints for the Calcitriol market along...Read More

Plant Sterol Esters Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts 2018–2026

Price : $ 3999.00 | Report Code: ZMR-3522 | Report Format:

Global Plant Sterol Esters Market: Overview Sterol esters are the heterogeneous chemical composites that are found in tiny proportions in eachcell type. These compounds are produced when sterol and fatty acids are esterified. Furthermore, plant sterols, which are found in fatty tissues of plants...Read More

Pharmaceutical Intermediates Market by Product Type (GMP and Non GMP), by Applications (Antibiotics, Antipyretic analgesics, Vitamins, and Others), and by Distribution Channel (Direct Sales and Distributor): Global Industry Perspective, Comprehensive Analysis and Forecast, 2017 – 2024

Oct-2018 | Price : $ 4899.00 | Pages: 110 | Report Code: ZMR-3440 | Report Format:

The report covers forecast and analysis for the pharmaceutical intermediates market on a global and regional level. The study provides historical data from 2015 to 2017 along with a forecast from 2018 to 2024 based on revenue (USD Million). The study includes drivers and restraints for the pharmac...Read More

Download Brochure
Why Choose Us ?

24/5 Research support

Resolved your research queries from industry expert. Request for a free research sample before report purchase.

Custom research service

Ask the Analyst to customize an exclusive study to serve your research needs.

Quality & Accuracy

Zion Market Research reports offers best quality reports based on various authentic and accurate data findings.

Customer Satisfaction

We ensure that our client's all research needs are met with customized, in-depth analysis solutions.

Information security

We never share your personal and confidential information. Your personal information is safe and secure with us.